|
Volumn 34, Issue 3, 2005, Pages 140-146
|
HER2 expression and its prognostic implication in lymph node negative breast carcinoma: a Meta-analysis
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
GENETICS;
HUMAN;
LYMPH NODE;
MASTECTOMY;
META ANALYSIS;
METABOLISM;
PATHOLOGY;
PROGNOSIS;
PROTO ONCOGENE;
SURVIVAL RATE;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FEMALE;
GENES, ERBB-2;
HUMANS;
LYMPH NODES;
MASTECTOMY;
PROGNOSIS;
RECEPTOR, ERBB-2;
SURVIVAL RATE;
|
EID: 39049175550
PISSN: 05295807
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|